Navigation Links
Zargis StethAssist & Zargis Cardioscan Cleared for Sale in Australia

STAMFORD, Conn., Feb. 23 /PRNewswire-FirstCall/ -- Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE), today announced that Australia's Therapeutic Goods Administration, the Australian equivalent of the U.S. FDA, has cleared the Zargis StethAssist™ and Zargis Cardioscan™ devices for sale in Australia.

StethAssist allows healthcare professionals to record and visualize heart, lung and other body sounds and share the findings via the Internet with colleagues. The Cardioscan heart sound analysis software is designed to help physicians analyze cardiac sounds for the identification and classification of suspected heart murmurs, which can be signs of heart disease.  Both devices connect wirelessly to a Bluetooth®-enabled digital stethoscope for the recording and playback of sounds.

Zargis Medical was a co-recipient of Popular Science magazine's 2009 "Innovation of the Year" award for Cardioscan. A Popular Science video regarding Cardioscan may be viewed at

Australia's population of more than 21 million people is served by approximately 48,000 physicians, making the nation an important market for Zargis. In addition, the country's vast physical size, and the fact that 34% of Australia's population resides in rural and remote regions, makes the telemedicine capabilities of StethAssist and Cardioscan a strong fit for the Australian healthcare system. The introduction of these devices into Australia will provide benefits during face-to-face patient encounters and allow healthcare providers to extend the use of auscultation (listening with a stethoscope) through the Internet to situations and environments where face-to-face encounters are not practical.

This clearance allows Zargis to immediately begin marketing StethAssist, Cardioscan and the compatible stethoscope in all Australian states and territories. To order Cardioscan or inquire about distribution opportunities visit

About Zargis Medical Corp.

Zargis is a global medical device company focused on improving health outcomes and cost-effectiveness through diagnostic support software and innovation. Zargis is majority-owned by Speedus Corp. (NASDAQ: SPDE), and both 3M Company and Siemens Corporate Research, a division of Siemens AG (NYSE: SI), hold equity positions.

For additional information about Zargis or Speedus Corp., contact Peter Hodge at 888.773.3669 (ext. 23) or, or visit the following Web sites: and

Statements contained herein that are not historical facts, including but not limited to statements about the Company's product, corporate identity and focus, may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by the Company, including, but not limited to, the continuing development of the Company's sales, marketing and support efforts.

SOURCE Speedus Corp.

Back to top



SOURCE Speedus Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Speedus Engages Morgan Joseph to Evaluate Strategic Alternatives for Zargis Subsidiary
2. Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference
3. Zargis Cardioscan Cleared for Sale in Canada
4. Zargis Cardioscan(TM) Featured on The Early Show on CBS
5. Zargis Cardioscan The Intelligent Stethoscope Now Available on
6. Zargis Cardioscan Jointly Named as Finalist in 2010 Edison Best New Product Awards
7. Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays
8. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
9. Tata Interactive Systems Partners With Bersin & Associates for Exclusive Executive Learning Forum - TLF 2009
10. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
11. Robbins & Myers Announces Regular Quarterly Cash Dividend
Post Your Comments:
(Date:11/26/2015)... Nederland, November 26, 2015 ... Een nieuwe aanpak combineert immunotherapie met Bremachlorin-photodynamische ... ) --> ...      (Photo: ) ... Universitair Medisch Centrum (LUMC) blijkt ...
(Date:11/26/2015)... -- 3D bioprinting market is expected to ... report by Grand View Research Inc. Rising prevalence of chronic ... transplantation is expected to boost the market growth, as 3D ... --> 3D bioprinting market is expected to ... report by Grand View Research Inc. Rising prevalence of chronic ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the Global Cell Surface Testing ... Opportunities" report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology:
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official ... independent group of Microsoft Dynamics SL software users, partners, industry experts and representatives. ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment ... itself for not only fulfilling the needs of advisers and clients but going ... price and providing top-tier customer service. However, there's always room for improvement, which ...
(Date:11/27/2015)... ... 27, 2015 , ... CBD College is proud to announce that ... awarded accreditation to its Diagnostic Medical Sonography program. CBD College is honored to join ... twelve colleges and universities in the state of California make the cut. CBD College ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Dr. ... Medical Associates, Inc. and Dr. Tucker Bierbaum with Emergency Medicine at St., ... observed that both STEMI and Sepsis conditions present in similar ways and require time-critical ...
(Date:11/27/2015)... ... , ... Indosoft Inc., developer and distributor of the world-class ... (Long Term Support) into its Q-Suite 5.10 product line. , Making the change ... version of Asterisk that will receive not only security fixes, but feature and ...
Breaking Medicine News(10 mins):